Provided by Tiger Trade Technology Pte. Ltd.

Illumina

145.83
-4.3100-2.87%
Pre-market: 146.490.6600+0.45%06:26 EST
Volume:1.60M
Turnover:235.38M
Market Cap:22.28B
PE:32.69
High:150.14
Open:150.14
Low:145.65
Close:150.14
52wk High:153.06
52wk Low:68.70
Shares:152.80M
Float Shares:149.35M
Volume Ratio:0.90
T/O Rate:1.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.46
EPS(LYR):-7.6918
ROE:31.20%
ROA:9.15%
PB:9.36
PE(LYR):-18.96

Loading ...

Illumina appoints new chief medical officer amid leadership shifts

TIPRANKS
·
14 hours ago

Illumina Names Eric Green Chief Medical Officer as Everett Cunningham Departs

Reuters
·
14 hours ago

Illumina Appoints DR. Eric Green as Chief Medical Officer

THOMSON REUTERS
·
14 hours ago

Illumina to name Eric Green chief medical officer, Endpoints News reports

TIPRANKS
·
15 hours ago

Illumina and PREMIA partner to expand clinical access to CGP in Asia

prnewswire
·
Yesterday

Stock Track | Illumina Soars 5.04% Intraday as Grail Spinoff Eases Regulatory Pressure

Stock Track
·
Jan 06

Illumina Is Maintained at Buy by Guggenheim

Dow Jones
·
Jan 06

Should Illumina’s (ILMN) Grail Spinoff to Ease Regulatory Pressure Require Action From Investors?

Simply Wall St.
·
Jan 05

It’s Earnings Warning Season. How to Profit From Others’ Misery

Dow Jones
·
Jan 01

BUZZ-Life sciences and contract research stocks navigate turbulence in 2025

Reuters
·
Dec 31, 2025

Illumina Is Maintained at Hold by Canaccord Genuity

Dow Jones
·
Dec 22, 2025

What Illumina (ILMN)'s MyOme AI Genomics Partnership Means For Shareholders

Simply Wall St.
·
Dec 22, 2025

BUZZ-Jefferies updates ratings on life sciences firms for 2026

Reuters
·
Dec 17, 2025

Illumina Chief Legal Officer Scott M. Davies Reports Sale of Common Shares

Reuters
·
Dec 17, 2025

Illumina to Webcast Presentation at J.P. Morgan Healthcare Conference

Reuters
·
Dec 17, 2025

Illumina Is Maintained at Neutral by JP Morgan

Dow Jones
·
Dec 16, 2025

Illumina Partners with MyOme to Advance AI-Driven Genomic Health Solutions

Reuters
·
Dec 11, 2025

Illumina and Myome Strike Collaboration Deal Including Strategic Investment to Support Myome's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually

THOMSON REUTERS
·
Dec 11, 2025

Illumina SVP Jakob Wedel Christensen Reports Disposal of Common Shares

Reuters
·
Dec 10, 2025

Illumina Raises $500 Million in 4.75% Notes Offering

Reuters
·
Nov 26, 2025